Cantor Fitzgerald analyst Pablo Zuanic upgraded Aurora Cannabis to Overweight from Neutral with a price target of C$5.85, up from C$5.10. The analyst does not expect a worse quarter for the group than the September quarter. And even though little may change in the December quarter, positive catalysts align in 2020, Zuanic tells investors in a research note. Further, based on his read of the quarter for the group, he estimates Aurora is "overall in better shape than peers." The analyst highlights the company's "stable" pricing, "best-in-class" gross margins of 56%, which he notes are near three-times Tilray's (TLRY), and no signs of provisions for rebates and returns.